Intangible Assets (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Jul. 31, 2017
Fair value of the assets acquired				$ 620,000		$ 620,000
Intangible asset		$ 815,514		815,514
Loss on impairment				1,291,200
Accumulated amortization of intangible assets		308,953		308,953
Amortization		41,937	$ 123,038	$ 288,460	$ 327,642
2014 Long-Term Incentive Plan [Member] | Chief Commercial Officer [Member]
Number of restricted shares of common stock				60,000
Symplmed Pharmaceuticals LLC [Member] | Purchase Agreement [Member]
Purchase consideration	$ 620,000
Payment to acquire business	$ 300,000
Liabilities assumed			$ 320,000		$ 320,000
Fair value of the assets acquired		160,800
Intangible asset		$ 459,200		$ 459,200
Symplmed Technologies, LLC [Member]
Intangible asset							$ 75,000